Comparison

PF-9601N European Partner

Item no. TMO-T8849-5mg
Manufacturer TargetMol
CASRN 133845-63-3
Amount 5mg
Category
Type Inhibitors
Specific against other
Purity 99.87%
Citations Unzeta M, Sanz E. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease. Int Rev Neurobiol. 2011;100:217-236. doi:10.1016/B978-0-12-386467-3.00011-X
Smiles C#CCNCC(N1)=CC2=C1C=CC(OCC3=CC=CC=C3)=C2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 133845-63-3, MAO
Available
Short Description
PF-9601N showed high potency and selectivity as a MAO-BI (monoamine oxidase type B inhibitor) and also demonstrated remarkable neuroprotective properties in several in vivo and cellular models of PD.
Shipping
cool pack
Storage
-20°
Molecular Weight
290, 4
Pathway
Metabolism|||Neuroscience
Target
MAO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close